2014
Concordance between Molecular and Phenotypic Testing of Mycobacterium tuberculosis Complex Isolates for Resistance to Rifampin and Isoniazid in the United States | 15.12.2014 (Daniel Goldenberger) Yakrus MA et al.: Concordance between Molecular and Phenotypic Testing of Mycobacterium tuberculosis Complex Isolates for Resistance to Rifampin and Isoniazid in the United States J Clin Microbiol 52 1932-1937 |
Effects of Vaccination on Invasive Pneumococcal Disease in South Africa | 08.12.2014 (Tamina Mosimann) A.von Gottberg et al.: Effects of Vaccination on Invasive Pneumococcal Disease in South Africa NEJM 371 1980 13.11.2014 |
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomized, observer-masked, placebo-controlled trial | 01.12.2014 (Maja Weisser) Capeding MR: Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomized, observer-masked, placebo-controlled trial Lancet 384 1385-65 2014 |
Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial | 24.11.2014 (Mario Kurz) Louis Bernard: Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial The Lancet 1-8 2014 |
Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK:results from the cross-sectional ASTRA study | 17.11.2014 (Marcel Stöckle) Daskalopoulou M. et al.: Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study Lancet HIV 1 e22-e31 2014 |
β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community Acquired Pneumonia | 10.11.2014 (Richard Kühl) Garin N. et al.: β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community Acquired Pneumonia JAMA Intern MedOnline: October 6, doi: 10.1001/jamainternmed.2014.4887 E1 bis E8 (online-Ausgabe) |
Antibiotic treatment failure in four common infections in UK primary care 1991-2013: longitudinal analysis | 27.10.2014 (Constantine Bloch-Infanger) Craig J Currie: Antibiotic treatment failure in four common infections in UK primary care 1991-2013: longitudinal analysis BMJ 349:g5493 Keine Seitenangaben 2014 |
Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users | 20.10.14 (Luigia Elzi) Barrella Harboe Z. et al.: Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users Clin Infect Dis 59 1168-76 2014 |
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis | 13.10.2014 (Veronika Bättig) Gillespie SH et al.: Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis NEJM [Epub ahead of print] 2014 Sep 7 |
A Systematic Review: Can One Prescribe Carbapenems to Patients With IgE-Mediated Allergy to Penicillins or Cephalosporins? | 06.10.2014 (Benedikt Wiggli) Kula B. et al.: A Systematic Review: Can One Prescribe Carbapenems to Patients With IgE-Mediated Allergy to Penicillins or Cephalosporins? CID 59(8) 1113–22 2014 |
Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy | 29.09.2014 (Adrian Egli) De Vlaminck I. et al.: Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy Cell 155 1178-1187 2013 |
Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections | 15.09.14 (Florian Banderet-Uglioni) Carapetis JR et al.: Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections CID 59 358-365 2014 http://www.ncbi.nlm.nih.gov/pubmed/25344540 |
Wastewater Treatment Plants Release Large Amounts of Extended-Spectrum ß-lactamse-producing Escherichia coli into the Environment | 08.09.2014 (Esther Künzli) Bréchet C et al.: Wastewater Treatment Plants Release Large Amounts of Extended-Spectrum ß-lactamse-producing Escherichia coli into the Environment CID 58 1658-1665 2014 |
Ritonavir-boosted darunavir combined with raltegravir or tenofovir—emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial | 25.08.2014 (Jan Sidler) Raffi F. et al.: Ritonavir-boosted darunavir combined with raltegravir or tenofovir—emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial Lancet NA (Epub ahead of print) NA (Epub ahead of print) 2014 |
Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial | 18.08.2014 (Tamina Mosimann) Alice C Eziefula et al.: Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial Lancet Infect Dis 14 130-139 2014 |
Impact of GeneXpert MTB/RIF on Triage of Respiratory Isolation Rooms for Inpatients with Presumed TB: A Hypothetical Trial. | 11.08.2014 (Michael Osthoff) Chaisson LH: Impact of GeneXpert MTB/RIF on Triage of Respiratory Isolation Rooms for Inpatients with Presumed TB: A Hypothetical Trial. Clin Infect Dis Aug 4. pii: ciu620. [Epub ahead of print] N/a 2014 |
Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials | 04.08.2014 (Sarah Tschudin Sutter) Crook D. W. et al.: Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials Clin Infect Dis 55 93-103 2012 |
ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV | 28.07.2014 (Adrian Schibli) P. Ferenci et al.: ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV NEJM 370 (21) 1983-1992 2014 |
Independent contribution of bronchioalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis | 21.07.2014 (Nina Khanna) Fisher CE et al.: Independent contribution of bronchioalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis Transpl Infect Dis 16 505-510 2014 |
Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis | 14.07.2014 (Elisabeth Wehrle) Boulware DR et al.: Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis NEJM 370;26 2487-2498 2014 www.ncbi.nlm.nih.gov/pubmed/2522993 |
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial | 07.07.2014 (Manuel Battegay) Grinsztejn B et al.: Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial Lancet Infect Dis 14 281–90 2014 |
Dalbavancin und Oritavancin, zwei neue Glycopeptid-Antibiotika zur Therapie von Haut und Weichteil-Infektionen | 30.06.2014 (Florian Banderet-Uglioni) 1. Corey G. et al.: Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections 2. Boucher A et al.: Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection NEJM 370 1. 2180-2190 1. 2169-2176 2014 |
Systematic PCR Detection on Culture-negative Osteoarticular Infections | 16.6.2014 (Daniel Goldenberger) Levy PY et al.: Systematic PCR Detection on Culture-negative Osteoarticular Infections Am J Med 1143 E25-e33 2013 |
Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation | 02.06.2014 (Mario Kurz) Rox F. Chemaly: Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation N Engl J Med 370 1781-1789 2014 |
Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients | 26.05.2014 (Bernardini Claudia) Kamar N. et al.: Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients NEJM 370: 1111-20 2014 |
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients? | 19.05.2014 (Aurélien Martinez) Roberts J. et al.: DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients? CID 58 (8) 1072-83 2014 |
Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome | 05.5.2014 (Barbara Jakopp) Sachiko et al.: Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome CID 58 Online Version; noch keine Seitenzahlen 2014 |
Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study | 14.04.2014 (Danielle Vuichard) Hayward AC. et al.: Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study Lancet Respir Med Published Online March 17, 2014 http://dx.doi.org/10.1016/ S2213-2600(14)70034-7 1-11 2014 |
Infectious Diseases Speciality Intervention Is Associated With Decreased Mortality and Lower Health Costs | 07.04.2014 (Adrian Schibli) Schmitt S. et al.: Infectious Diseases Speciality Intervention Is Associated With Decreased Mortality and Lower Health Costs CID 58 22-28 2014 |
Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection | 24.3.2014 (Egli Adrian) Liehl Peter et al: Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection Nature Medicine 20 47-52 2014 |
Impact of Rapid Organism Identification via Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Combined with Antimicrobial Stewardship Team Intervention in Adult Patients With Bacteremia and Candidemia | 17.03.2014 (Michael Osthoff) Huang AM et al.: Impact of Rapid Organism Identification via Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Combined with Antimicrobial Stewardship Team Intervention in Adult Patients With Bacteremia and Candidemia Clin Infect Dis Nov;57(9) 1237-45 2013 |
The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study | 03.03.2014 (Veronika Bättig) Nosyk B. et al.: The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study Lancet Infect Dis 14 40-49 2014 |
Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial | 24.02.2014 (Esther Künzli) Fry A. M. et al.: Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial Lancet Infect Dis 14 109-118 2014 |
Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort | 17.02.2014 (Aurélien Martinez) Peña C. et al: Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort Clin Infect Dis Jul;57(2): 208-16 2013 |
Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection | 10.02. 2014 (Marilia Santini de Oliveira) Karris MY et al.: Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection AIDS 3 Epub ahead of print 2014 |
A Trial of Mass Isoniazid Preventive Therapie for Tuberculosis Control | 03.02.2014 (Florian Banderet) Churchyard G. et al.: A Trial of Mass Isoniazid Preventive Therapie for Tuberculosis Control NEJM 370;4 301-310 2014 |
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection | 27.01.2014 (Mario Kurz) Mark S. Sulkowski: Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection N Engl J Med 307;3 211-221 2014 |
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial | 20.01.14 (Sarah Tschudin Sutter) Derde LP et al.: Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial Lancet Infect Dis 14 31-9 2013 |
Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus on an intensive care unit | 13.01.2014 (Botond Lakatos) Price JR et al.: Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus on an intensive care unit CID December 12. Epub ahead of print 2013 |
| Inactivation of Hepatitis C Virus Infectivity by Human Breast Milk | 06.01.14 (Barbara Jakopp) Stephanie Pfaender: Inactivation of Hepatitis C Virus Infectivity by Human Breast Milk JID 208 1943-52 2013 |